Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Bio Green Med Solution ( (BGMS) ).
On January 12, 2026, Bio Green Med Solution, Inc. announced that its board of directors declared a quarterly cash dividend of $0.15 per share on its 6% Convertible Exchangeable Preferred Stock, payable on February 1, 2026, to holders of record as of January 22, 2026. The move provides direct cash returns to preferred shareholders and signals the company’s continued commitment to servicing its preferred equity capital structure.
The most recent analyst rating on (BGMS) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on Bio Green Med Solution stock, see the BGMS Stock Forecast page.
Spark’s Take on BGMS Stock
According to Spark, TipRanks’ AI Analyst, BGMS is a Neutral.
The score is primarily held down by persistent losses and substantial cash burn relative to a very small revenue base, despite an improved and low-debt balance sheet. Technicals further weigh on the outlook as the stock remains below major moving averages with negative MACD. Valuation is mixed: a high dividend yield is supportive, but negative earnings and weak cash generation limit its impact.
To see Spark’s full report on BGMS stock, click here.
More about Bio Green Med Solution
Average Trading Volume: 339,344
Technical Sentiment Signal: Strong Sell
Current Market Cap: $6.71M
For detailed information about BGMS stock, go to TipRanks’ Stock Analysis page.